AlphaFold predicted structure
PPM1D · O15297

Mean pLDDT
67.9/ 100
Low
605 residues
Confidence breakdown
- Very high(≥ 90)43%
- Confident(70–90)9%
- Low(50–70)6%
- Very low(< 50)43%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
protein phosphatase, Mg2+/Mn2+ dependent 1D
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFamilial breast cancer
Fetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownInherited ovarian cancer (without breast cancer)
intellectual developmental disorder with gastrointestinal difficulties and high pain threshold
hereditary disease
neurodegenerative disease
hereditary breast carcinoma
Hereditary breast cancer
ovarian carcinoma
malignant glioma
syndromic intellectual disability
colorectal adenocarcinoma
essential thrombocythemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Protein phosphatase 1D
Involved in the negative regulation of p53 expression (PubMed:23242139). Required for the relief of p53-dependent checkpoint mediated cell cycle arrest. Binds to and dephosphorylates 'Ser-15' of TP53 and 'Ser-345' of CHEK1 which contributes to the functional inactivation of these proteins (PubMed:15870257, PubMed:16311512). Mediates MAPK14 dephosphorylation and inactivation (PubMed:21283629). Is also an important regulator of global heterochromatin silencing and critical in maintaining genome integrity (By similarity)
PPM1D · O15297

Mean pLDDT
67.9/ 100
Low
605 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0